Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00828802 · ClinicalTrials.gov registry record · Phase 1
Lenalidomide and Decitabine in High Grade Myelodysplastic Syndromes
A Phase 1 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 1
- Development phase
- 15
- Enrollment target
NCT00828802 is a Phase 1 study that has completed, run by Duke University. The registered enrollment target is 15 participants.
The verdict
NCT00828802, a Phase 1 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of this study is to find out what dose of lenalidomide is safe to use in combination with decitabine when given in people with myelodysplastic syndrome.
Interventions
- DRUG Lenalidomide, Decitabine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2009-03 |
| Est. Completion | 2012-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00828802
The ClinicalTrials.gov registry entry for NCT00828802 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lenalidomide, Decitabine is the first listed.
NCT00828802 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00828802 about?
NCT00828802 is a clinical study titled "Lenalidomide and Decitabine in High Grade Myelodysplastic Syndromes". The purpose of this study is to find out what dose of lenalidomide is safe to use in combination with decitabine when given in people with myelodysplastic syndrome.
What is the current status of trial NCT00828802?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2009-03. Estimated completion is 2012-11.
What interventions are being tested in trial NCT00828802?
The interventions under investigation include: Lenalidomide, Decitabine (DRUG).
Who is sponsoring clinical trial NCT00828802?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.